Our current data indicate that p53 is the upstream transcription factor that leads to LincRNA-p21 induction in obesity-related kidney lesions, proposing a novel mechanism by which p53 participates in the progression of metabolic disease.5 The gene discussed is CDKN1A; the disease is Obesity.